Display Options:
Total: 1404
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Leukemia; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms, Plasma Cell
Transferrin receptor protein 1 antagonist
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell
Leukocyte antigen CD37 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Autoimmune Diseases; Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Interleukin-3 receptor subunit alpha inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Proheparin-binding EGF-like growth factor inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 binding agent
Antibody
Investigational
Unknown
Unknown
Ovarian Neoplasms
Epithelial cell adhesion molecule other
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Neoplasms
Teratocarcinoma-derived growth factor 1 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Glycoprotein inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Immunostimulant
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Histiocytoma, Malignant Fibrous
Unknown
Antibody
Unknown
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
Antibody
Unknown
Unknown
Unknown
Breast Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Tumor-associated antigen 72 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Delta-like protein 4 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Glycoprotein inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Bone Diseases, Metabolic
Sclerostin inhibitor
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Cell surface A33 antigen binding agent
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Pancreatic Neoplasms
Frizzled-1 antagonist
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms
Glutamate carboxypeptidase II binding agent
Antibody
Investigational
Unknown
Unknown
Adenocarcinoma
Carcinoembryonic antigen-related cell adhesion molecule 5 cross-linking agent
Antibody
Investigational
Unknown
Unknown
Melanoma
5,6-dihydroxyindole-2-carboxylic acid oxidase other